|
 
 
Thrombosis Research Section Faculty
Faculty (Secondary Appointment)
Research Interests:
Dr. Teruya is Assistant Professor of Pathology, Pediatrics, and Medicine.
He is Director of Blood Bank and Coagulation and Director of
Pheresis at Texas Children's Hospital.
Dr. Teruya's research interests include: 1. Developing a new assay
method for heparin antibodies. With flow cytometry using platelet
activation markers such as CD62, CD 41, and CD45, a new method is
being investigated to detect patients who have a risk for heparin-induced
thrombocytopenia/thrombosis. 2. Whole blood coagulation technology
in the assessment of bleeding and thrombosis. Hemostasis is regulated
not only by plasma proteins and platelets, but also by cellular components
such as neutrophils and red cells. Dr. Teruya is investigating further
application of thromboelastography using citrated whole blood for
detection of hypercoagulable state in patients with nephrotic syndrome
and sickle cell disease. Dr. Teruya's unique strength is his outstanding
expertise in clinical coagulation from the Clinical Pathology viewpoint
of specialized coagulation testing.
Selected Publications:
1. Teruya, J. Practical issues in therapeutic apheresis. Therapeutic
Apheresis 2002;6:288-9. (Official Journal of the International
Society for Apheresis.)
2. Teruya, J., Styler, M., Verde, S., Topolsky, D., and Crilley,
P. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic
purpura after bone marrow transplantation. J Clin Apheresis
2001;16:169-74.
3. Diaz, L. and Teruya, J. Hemostatic contraindications to the liver
biopsy. [Letter] N Engl J Med 2001;344:2030.
4. Teruya, J., Oropeza, M., and Ramsey, G. A normal PTT does not
guarantee adequate coagulation factor levels. Anesthesiology
2001;94:542.
5. Teruya, J. and Styler, M. Management of factor XI inhibitor for
cardiac intervention: Successful treatment with immunosuppressive
therapy and plasma exchange. Haemophilia 2000;6:158-161.
6. Haas, J., Jernick, S., Scardina, RJ., Teruya, J., Caliendo, AM.,
and Ruoff, KL. Colonization of skin by Helcococcus kunzii.
Journal of Clinical Microbiology 1997;35:2759-2761.
7. Hallaq, Y., Szczepiorkowski, ZM., Teruya, J., Cluette?Brown, J.,
and Laposata, M.Stability of plasma nonesterified arachidonate in
healthy individuals in fasting and nonfasting states. Clinical
Chemistry 1996;42:771-773.
8. Cher, LM.,. Hochberg, FH., Teruya, J., Nitschke, M., Valenzuela,
RF.,Schmahmann, J., Herbert, M., Rosas, D., and Stowell, CP. Therapy
for paraneoplastic neurologic syndromes in six patients with protein
A column immunoadsorption. Cancer 1995;75:1678-1683.
9. Teruya, J., Pins, MR., and Stowell, CP. Effectiveness of protein
A column treatment for patients with paraneoplastic neurologic syndromes.
Japanese Journal of Apheresis 1995;14:51-52.
10. Teruya, J., Cluette-Brown, J., Szczepiorkowski, ZM., and Laposata,
M. Mode of transport of fatty acid to endothelial cells influences
intracellular fatty acid metabolism. Journal of Lipid Research
1995;36:266-276.
 ©1995-2003
Baylor College of Medicine
Email: medicine@bcm.tmc.edu
URL: http://public.bcm.tmc.edu/medicine/teruya.htm (Modified: June 10, 2003)
|
